Emory Athletics Joins The Fight Against Breast Cancer
October marks the beginning of Breast Cancer Awareness month and the start of the Emory Eagles THINK PINK campaign. THINK PINK is a joint effort of the Emory University Athletic Department, Winship Cancer Institute, Emory's Women's Center, the Student Programming Council and the entire University community in the fight against the dreaded disease.
Beginning October 4th and continuing through February 21st, the Emory Eagles will be raising money for breast cancer research on the Atlanta, GA campus. Some of the fundraising efforts will include the sale of Emory Eagles pink merchandise, as well as Breast Cancer Awareness merchandise donated by the A & E Group. The fundraising initiative will culminate for a week of events in February that will remind everyone to THINK PINK.
The Emory Eagles Volleyball team will be joining the fight as they "Dig Pink". The University Athletic Association (UAA) along with the University of Rochester will be hosting the UAA Round Robin October 3-4th. During this event, the members of the UAA will be supporting the idea that education is key to increasing awareness and knowledge about the disease.
The original "Think Pink" campaign was conceived by the Women's Basketball Coaches Association (WBCA) prior to the 2006-07 season in an effort to raise breast cancer awareness in women's basketball, college campuses and communities. Last year, more than 1,800 schools joined forces in the effort and helped make the year a rousing success.
Breast Cancer Research at Emory Winship Cancer Institute
Breast cancer affects so many lives: The American Cancer Society reports that more than 2 million American women have undergone treatment for breast cancer. Researchers at Emory are working hard to find new ways to prevent, diagnose, and treat this serious disease, and the prognosis looks very promising.
The Breast Cancer Program is comprised of a diverse group of 18 members from nine different departments. The primary goals for the program are:
- The development of trials examining the use of chemotherapy and targeted agents pre-operative to allow correlation of molecular profiles with response to therapy;
- The development of an Emory-wide prospective breast cancer tumor bank to compare molecular profiles between patients based on race and age; and
- The development of unique breast-imaging techniques.
